Accuray (ARAY) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Accuray | 47,295.88 | -38.49 Mn | 25.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.19% |
| Dec 31, 2025 | -7.24% |
| Sep 30, 2025 | -1.71% |
| Jun 30, 2025 | 4.99% |
| Mar 31, 2025 | 17.20% |
| Dec 31, 2024 | -3.08% |
| Sep 30, 2024 | 1.99% |
| Jun 30, 2024 | -2.00% |
| Mar 31, 2024 | -5.71% |
| Dec 31, 2023 | 0.65% |
| Sep 30, 2023 | 1.58% |
| Jun 30, 2023 | 1.99% |
| Mar 31, 2023 | -5.59% |
| Dec 31, 2022 | 1.05% |
| Sep 30, 2022 | -0.69% |
| Jun 30, 2022 | 2.71% |
| Mar 31, 2022 | -7.64% |
| Dec 31, 2021 | 1.80% |
| Sep 30, 2021 | -3.03% |
| Jun 30, 2021 | 2.90% |
| Mar 31, 2021 | -13.92% |
| Dec 31, 2020 | 5.02% |
| Sep 30, 2020 | 1.01% |
| Jun 30, 2020 | -3.43% |
| Mar 31, 2020 | -21.76% |
| Dec 31, 2019 | -5.91% |
| Sep 30, 2019 | -12.63% |
| Jun 30, 2019 | -12.74% |
| Mar 31, 2019 | -13.04% |
| Dec 31, 2018 | -13.48% |
| Sep 30, 2018 | -13.03% |
| Jun 30, 2018 | -35.17% |
| Mar 31, 2018 | -18.17% |
| Dec 31, 2017 | -20.10% |
| Sep 30, 2017 | -22.41% |
| Jun 30, 2017 | -25.58% |
| Mar 31, 2017 | -26.45% |
| Dec 31, 2016 | -26.95% |
| Sep 30, 2016 | -25.91% |
| Jun 30, 2016 | -24.32% |
| Jun 30, 2015 | -14.93% |